US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist

2.710
+0.030+1.12%

Close Apr 23 16:00 ET

70.28MMarket Cap-6609P/E (TTM)

Anebulo Pharmaceuticals Stock Forum

Trytosaveabit

Jan 11 19:48

Watching for answer

$Anebulo Pharmaceuticals(ANEB.US)$ Anebulo Pharmaceuticals Filed U.S. Patent Application #20240010617: Crystalline Forms Of A Cannabinoid Receptor Type 1 (Cb1) Modulator And Methods Of Use And Preparation Thereof

Trytosaveabit

Aug 21, 2023 20:07

LIKE!

$Anebulo Pharmaceuticals(ANEB.US)$ Anebulo Receives Positive Feedback From FDA On Path To Advance Phase 3 Clinical Development Of ANEB-001 And Completes Dosing Of Phase 2 Extension.